The mechanisms of drug release in poly (lactic-co-glycolic acid)-based drug delivery systems—A review

S Fredenberg, M Wahlgren, M Reslow… - International journal of …, 2011 - Elsevier
Abstract Poly (d, l-lactic-co-glycolic acid)(PLGA) is the most frequently used biodegradable
polymer in the controlled release of encapsulated drugs. Understanding the release …

PLGA-based nanoparticles as cancer drug delivery systems

FS Tabatabaei Mirakabad, K Nejati-Koshki… - Asian Pacific Journal …, 2014 - koreascience.kr
Poly (lactic-co-glycolic acid)(PLGA) is one of the most effective biodegradable polymeric
nanoparticles (NPs). It has been approved by the US FDA to use in drug delivery systems …

Titanium oxide antibacterial surfaces in biomedical devices

L Visai, L De Nardo, C Punta… - … journal of artificial …, 2011 - journals.sagepub.com
Titanium oxide is a heterogeneous catalyst whose efficient photoinduced activity, related to
some of its allotropic forms, paved the way for its widespread technological use. Here, we …

[HTML][HTML] Solvent-cast direct-writing and electrospinning as a dual fabrication strategy for drug-eluting polymeric bioresorbable stents

V Chausse, E Casanova-Batlle, C Canal… - Additive …, 2023 - Elsevier
Bioresorbable stents (BRS) are conceived to retain sufficient radial strength after
implantation while releasing an antiproliferative drug in order to prevent vessel restenosis …

[HTML][HTML] Anticancer activity of nanoparticles based on PLGA and its co-polymer: in-vitro evaluation

I Amjadi, M Rabiee, MS Hosseini - Iranian journal of …, 2013 - ncbi.nlm.nih.gov
Attempts have been made to prepare nanoparticles based on poly (lactic-co-glycolic
acid)(PLGA) and doxorubicin. Biological evaluation and physio-chemical characterizations …

Synthesis and Characterization of Doxorubicin-Loaded Poly(Lactide-co-glycolide) Nanoparticles as a Sustained-Release Anticancer Drug Delivery System

I Amjadi, M Rabiee, MS Hosseini… - Applied biochemistry and …, 2012 - Springer
The objective of the present study was to prepare a polymeric drug delivery system with no
burst effect. To attain this goal, doxorubicin (Dox) as an effective anticancer drug was loaded …

Review of polyhydroxyalkanoates materials and other biopolymers for medical applications

Y Chen, ST Hung, E Chou… - Mini-Reviews in Organic …, 2018 - ingentaconnect.com
Polyhydroxyalkanoates (PHAs) and other biopolymers vary in their behavior and properties,
but are extremely useful in medical applications because of their biodegradability. As long …

Novel biodegradable nanocarriers for enhanced drug delivery

M Gagliardi - Therapeutic delivery, 2016 - Taylor & Francis
With the refinement of functional properties, the interest around biodegradable materials, in
biorelated applications and, in particular, in their use as controlled drug-delivery systems …

In vitro dissolution testing of drug-eluting stents

A Seidlitz, S Nagel, B Semmling… - Current …, 2013 - ingentaconnect.com
Drug-eluting stents (DES) have revolutionized the treatment of coronary artery blockage by
tremendously reducing the rate of in-stent restenosis and the necessity of repeat …

Drug eluting stents based on Poly (ethylene carbonate): optimization of the stent coating process

N Bege, SO Steinmüller, M Kalinowski, R Reul… - European journal of …, 2012 - Elsevier
First generation drug eluting stents (DES) show a fivefold higher risk of late stent thrombosis
compared to bare metal stents. Therefore, new biodegradable and biocompatible polymers …